Establishment of a causal link between AD and L1 retrotransposons
AD 和 L1 反转录转座子之间因果关系的建立
基本信息
- 批准号:10704226
- 负责人:
- 金额:$ 78.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAstrocytesAutopsyBiological ModelsBrainCRISPR/Cas technologyCell AgingCell DeathCellsChronicCollectionCytoplasmDNADataDiseaseDisease ProgressionElementsEvolutionGene ExpressionGenomeGenomicsGoalsHumanImmune systemImmunologic StimulationIndividualInflammationInflammatoryInterferon ActivationInterferonsL1 ElementsLinkMeasuresMicrogliaModelingMolecularNeurogliaNeuronsNucleosidesOrganoidsOutcome StudyPathogenesisPathway interactionsPhenotypeProtective AgentsProtocols documentationRNA-Directed DNA PolymeraseRetrotransposonReverse Transcriptase InhibitorsReverse TranscriptionSeriesSingle-Stranded DNASiteSterilitySynapsesSyndromeTestingTherapeuticage effectbrain cellcell typecytokinedesignexperimental studyhuman diseasehuman modelhuman tissueimprovedinduced pluripotent stem cellinsightmutantneural networkneurotoxicneurotoxicitynoveloverexpressionprematureresponsesynaptogenesistau aggregationtau-1transcriptomicswhole genome
项目摘要
Abstract
Our overall goal is to determine a potential causal link between L1, an active retrotransposon element, in
human brain cells and Alzheimer's Disease (AD). L1s are involved in numerous human diseases with different
molecular and cellular mechanisms. L1 expression was also found to be upregulated in AD postmortem human
tissues, leading to the speculation that L1s could contribute, at least partially, to the mechanisms leading to AD
in humans. However, despite all these correlations, there is no experimental-based causal link between L1s
and AD so far. Here, we hypothesized that L1 expression in AD-derived brain cells can contribute to AD
pathology, using both cell-autonomous and non-cell-autonomous mechanisms. Accumulation of L1-derived
ssDNA molecules in the cytoplasm of glial cells might be responsible for a chronic low-level stimulation of the
immune system, aka “sterile” inflammation, and can aggravate molecular and cellular phenotypes in neurons
derived from AD patients. Moreover, a cell autonomous mechanism, triggered by L1 ssDNA accumulation in
neurons could accelerate and exacerbate molecular and cellular phenotypes related to AD pathogenesis.
Thus, the combinatory impact of L1 expression in the different cell types could causally contribute to AD. To
experimentally test this hypothesis, we will use induced pluripotent stem cells (iPSC) from controls and AD to
overexpress L1 ssDNA molecules and analyze their impact on different neuronal types individually or in
combination using a brain organoid model system. The use of iPSC-derived cells and organoid model is
perfectly suited as we can isolate the aging effect and capture the entire genome of AD individuals in relevant
cell types. We have designed the following specific aims to test our hypothesis: Aim 1: Determine the impact
of L1 retrotransposons in AD-derived astrocytes. We will measure alterations in transcriptomics,
cytokines/interferon release levels and interferon-stimulated gene (ISGs) expression in AD/isogenic-derived
astrocytes upon L1 ssDNA overexpression. We will also evaluate neurotoxicity using astrocyte conditioned
media from AD-derived astrocytes overexpressing L1 ssDNA. Aim 2: Determine the impact of L1
retrotransposons in AD-derived cortical neurons. We will measure Tau aggregation and phosphorylation,
and synaptic loss, all early hallmarks of the AD progression. Aim 3: To model AD progression with a brain
organoid model. We will use our optimized protocol to generate brain cortical organoids (BCO) infused with
human microglia from AD- and control individuals. BCO with L1 ssDNA but treated with nucleoside reverse
transcriptase inhibitors (NRTI) as a protective agent, will be compared. Our proposal aims to demonstrate an
eventual causal contribution of L1-derived ssDNA to molecular, cellular and network phenotypes in brain cells
and organoids derived from AD individuals. Our data will reveal unexplored pathways with immediate
therapeutic relevance that could lead to transformative treatments for AD and other aging-related syndromes.
摘要
我们的总体目标是确定L1(一种活跃的反转录转座子元件)与
人类脑细胞和阿尔茨海默病(AD)。L1与许多人类疾病有关,
分子和细胞机制。L1表达在AD尸检中也被发现上调,
组织,导致推测L1可能有助于,至少部分地,导致AD的机制
在人类身上。然而,尽管有这些相关性,L1之间并没有基于实验的因果联系
AD至今在这里,我们假设AD源性脑细胞中的L1表达可能导致AD
病理学,使用细胞自主和非细胞自主机制。L1衍生的蓄积
胶质细胞胞质中的ssDNA分子可能是导致慢性低水平刺激胶质细胞的原因。
免疫系统,又名“无菌”炎症,并可加重神经元中的分子和细胞表型
来自AD患者。此外,L1 ssDNA积累触发的细胞自主机制,
神经元可加速和加重与AD发病机制相关的分子和细胞表型。
因此,L1在不同细胞类型中表达的组合影响可能导致AD。到
为了通过实验验证这一假设,我们将使用来自对照组和AD的诱导多能干细胞(iPSC),
过表达L1 ssDNA分子,并分析它们对不同神经元类型的影响,
使用脑类器官模型系统的组合。iPSC衍生的细胞和类器官模型的使用是
非常适合,因为我们可以分离衰老效应并捕获相关AD个体的整个基因组,
细胞类型。我们设计了以下具体目标来验证我们的假设:目标1:确定影响
L1反转录转座子在AD衍生的星形胶质细胞中的表达。我们将测量转录组学的变化,
细胞因子/干扰素释放水平和干扰素刺激的基因(ISG)表达在AD/等基因源性
星形胶质细胞L1 ssDNA过表达。我们还将评估神经毒性使用星形胶质细胞条件
来自过表达L1 ssDNA的AD衍生的星形胶质细胞的培养基。目标2:确定L1的影响
逆转录转座子在AD衍生的皮质神经元中的表达。我们将测量Tau的聚集和磷酸化,
和突触丢失,这些都是AD进展的早期标志目的3:用大脑模拟AD进展
类器官模型我们将使用我们的优化方案来生成注入有
来自AD和对照个体的人小胶质细胞。使用L1 ssDNA但经核苷逆转治疗的BCO
转录酶抑制剂(NRTI)作为保护剂,将进行比较。我们的建议旨在展示一个
L1衍生的ssDNA对脑细胞中分子、细胞和网络表型的最终因果作用
和源自AD个体的类器官。我们的数据将揭示未探索的途径,
这可能导致AD和其他衰老相关综合征的变革性治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alysson R. Muotri其他文献
Generation of ‘semi-guided’ cortical organoids with complex neural oscillations
具有复杂神经振荡的“半引导”皮质类器官的生成
- DOI:
10.1038/s41596-024-00994-0 - 发表时间:
2024-05-03 - 期刊:
- 影响因子:16.000
- 作者:
Michael Q. Fitzgerald;Tiffany Chu;Francesca Puppo;Rebeca Blanch;Miguel Chillón;Shankar Subramaniam;Alysson R. Muotri - 通讯作者:
Alysson R. Muotri
ヒトiPS細胞からブレインオルガノイドを作製する
利用人类 iPS 细胞创建大脑类器官
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
中嶋 秀行;Cleber A. Trujillo;石津 正崇;潘 淼;Alysson R. Muotri;中島 欽一 - 通讯作者:
中島 欽一
The impact of antidepressants on human neurodevelopment: Brain organoids as experimental tools
抗抑郁药对人类神经发育的影响:脑类器官作为实验工具
- DOI:
10.1016/j.semcdb.2022.09.007 - 发表时间:
2023-07-30 - 期刊:
- 影响因子:6.000
- 作者:
Luciana Simões Rafagnin Marinho;Gabrielly Maria Denadai Chiarantin;Juliane Midori Ikebara;Débora Sterzeck Cardoso;Théo Henrique de Lima-Vasconcellos;Guilherme Shigueto Vilar Higa;Mariana Sacrini Ayres Ferraz;Roberto De Pasquale;Silvia Honda Takada;Fabio Papes;Alysson R. Muotri;Alexandre Hiroaki Kihara - 通讯作者:
Alexandre Hiroaki Kihara
Graphene-polymer nanofibers enable optically induced electrical responses in stem cell-derived electrically excitable cells and brain organoids
石墨烯 - 聚合物纳米纤维使干细胞衍生的可兴奋电细胞和脑类器官能够产生光诱导的电响应
- DOI:
10.1016/j.biomaterials.2025.123430 - 发表时间:
2025-12-01 - 期刊:
- 影响因子:12.900
- 作者:
Erin LaMontagne;Alex Savchenko;Gisselle Gonzalez;Ritwik Vatsyayan;Blanca Martin-Burgos;Francesca Puppo;Diogo Biagi;Fabio Papes;Shadi A. Dayeh;Alysson R. Muotri;Adam J. Engler - 通讯作者:
Adam J. Engler
Peering into the mind: unraveling schizophrenia’s secrets using models
窥视心灵:利用模型揭示精神分裂症的秘密
- DOI:
10.1038/s41380-024-02728-w - 发表时间:
2024-09-08 - 期刊:
- 影响因子:10.100
- 作者:
João V. Nani;Alysson R. Muotri;Mirian A. F. Hayashi - 通讯作者:
Mirian A. F. Hayashi
Alysson R. Muotri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alysson R. Muotri', 18)}}的其他基金
Impact of prenatal inflammation on developing human brain
产前炎症对人类大脑发育的影响
- 批准号:
10705556 - 财政年份:2022
- 资助金额:
$ 78.47万 - 项目类别:
A new brain organoid model for NeuroHIV and the impact of opioids
NeuroHIV 的新脑类器官模型以及阿片类药物的影响
- 批准号:
10693976 - 财政年份:2022
- 资助金额:
$ 78.47万 - 项目类别:
Establishment of a causal link between AD and L1 retrotransposons
AD 和 L1 反转录转座子之间因果关系的建立
- 批准号:
10519029 - 财政年份:2022
- 资助金额:
$ 78.47万 - 项目类别:
A new brain organoid model for NeuroHIV and the impact of opioids
NeuroHIV 的新脑类器官模型以及阿片类药物的影响
- 批准号:
10529106 - 财政年份:2022
- 资助金额:
$ 78.47万 - 项目类别:
Impact of prenatal inflammation on developing human brain
产前炎症对人类大脑发育的影响
- 批准号:
10387980 - 财政年份:2022
- 资助金额:
$ 78.47万 - 项目类别:
The impact of hiPSC-derived microglia in human brain development in health and disease
hiPSC 衍生的小胶质细胞对健康和疾病中人脑发育的影响
- 批准号:
10279492 - 财政年份:2021
- 资助金额:
$ 78.47万 - 项目类别:
Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model
使用人体模型研究皮特霍普金斯综合症的病理生理学
- 批准号:
10553718 - 财政年份:2021
- 资助金额:
$ 78.47万 - 项目类别:
Investigation of Pitt-Hopkins Syndrome pathophysiology using a human model
使用人体模型研究皮特霍普金斯综合症的病理生理学
- 批准号:
10208365 - 财政年份:2021
- 资助金额:
$ 78.47万 - 项目类别:
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease
hiPSC 衍生的小胶质细胞对健康和疾病中人脑发育的影响
- 批准号:
10458040 - 财政年份:2021
- 资助金额:
$ 78.47万 - 项目类别:
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease
hiPSC 衍生的小胶质细胞对健康和疾病中人脑发育的影响
- 批准号:
10661578 - 财政年份:2021
- 资助金额:
$ 78.47万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 78.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)